Aonong Group(SH:603363)2023-04-28 16:00Financial Performance - The company's operating revenue for Q1 2023 was ¥4,817,861,444.34, representing a year-on-year increase of 15.95% compared to ¥4,155,179,534.35 in the same period last year[5]. - The net profit attributable to shareholders of the listed company was -¥179,712,567.24, an improvement from -¥351,683,571.56 in the previous year[5]. - The basic earnings per share for Q1 2023 was -¥0.21, an improvement from -¥0.54 in the same period last year[6]. - Net profit for Q1 2023 was -250,464,569.13 RMB, compared to -486,086,893.54 RMB in Q1 2022, showing an improvement in losses[22]. - The total comprehensive income attributable to the parent company was -CNY 180,069,927.08, an improvement from -CNY 351,607,769.91 in Q1 2022[23]. - In Q1 2023, the company reported a net loss of CNY 250,821,928.97, compared to a net loss of CNY 486,011,091.89 in Q1 2022, showing an improvement of approximately 48.5% year-over-year[23]. Cash Flow - The net cash flow from operating activities increased by 89.26%, reaching ¥252,705,770.68, compared to ¥133,520,190.55 in the same period last year[6]. - The net cash flow from operating activities for Q1 2023 was $106,699,219.81, a decrease of 65.0% compared to $305,241,587.05 in Q1 2022[33]. - The net cash flow from financing activities was -CNY 288,001,357.76, compared to a positive cash flow of CNY 306,356,490.18 in the same quarter last year[25]. - The net cash flow from investment activities was $73,110,306.03, a recovery from a negative cash flow of $104,748,039.37 in the same quarter last year[33]. Assets and Liabilities - Total assets at the end of the reporting period were ¥18,555,272,425.30, a decrease of 0.85% from ¥18,660,568,970.85 at the end of the previous year[6]. - Total liabilities for Q1 2023 were 15,423,031,050.08 RMB, compared to 15,279,481,765.73 RMB in the previous period, indicating a slight increase[20]. - The company's total equity decreased to 3,132,241,375.22 RMB in Q1 2023 from 3,434,856,758.48 RMB in the previous period, a decline of approximately 8.8%[20]. - The company's total current assets amounted to RMB 5.3289 billion, an increase from RMB 5.1153 billion at the end of 2022[18]. Shareholder Information - The total number of ordinary shareholders at the end of the reporting period was 81,482[10]. - The largest shareholder, Xiamen Aonong Investment Co., Ltd., held 37.01% of the shares, with a significant portion pledged[11]. Operational Metrics - In Q1 2023, the company sold 1.3859 million pigs, representing a year-on-year increase of 32.40%[15]. - As of March 31, 2023, the company's pig inventory was 2.4296 million, up 28.40% compared to March 31, 2022, but down 0.20% from December 31, 2022[15]. Research and Development - Research and development expenses for Q1 2023 amounted to 47,317,920.67 RMB, which is an increase from 32,638,151.04 RMB in Q1 2022, reflecting a growth of approximately 45.1%[22]. - Research and development expenses increased to CNY 23,278,596.98 in Q1 2023, up from CNY 8,243,292.61 in Q1 2022, reflecting a focus on innovation[30]. Investment Activities - The company transferred 90% of its stake in Fujian Yixinbao Biopharmaceutical Co., Ltd. to its controlling shareholder for RMB 110.75265 million, reducing its ownership to 10%[16]. - The company plans to raise up to RMB 1.8 billion through a private placement to fund feed and food slaughter projects, acquire minority stakes in breeding subsidiaries, and supplement working capital[15].